Back
Pros Holdings Vs. Blueprint Medicines Industry Stock Comparison
Sell
40
PRO
Pros Holdings
Last Price:
$15.30
Seasonality Move:
2.17%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.10
Seasonality Move:
10.35%
Sell
40
Pros Holdings (PRO)
is a Sell
Is Pros Holdings a Buy, Sell or Hold?
-
The current Pros Holdings [PRO] share price is $14.97. The Score for PRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
PRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.25. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRO Stock Price Chart
What is Pros Holdings's stock price today?
-
The Pros Holdings share price today is $14.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.25The current trend is moderately bullish and BPMC is experiencing slight selling pressure.
PRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.94 | Sell |
Relative Strength Index (14 RSI): | 37.64 | Sell |
Chaikin Money Flow: | 693885 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (15.27 - 18.93) | Sell |
Bollinger Bands (100): | (16.03 - 23.51) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.66 | Buy |
Relative Strength Index (14 RSI): | 75.28 | Buy |
Chaikin Money Flow: | -188052 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (106.53 - 132.13) | Buy |
Bollinger Bands (100): | (84.83 - 114.87) | Buy |
PRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.7 | Buy |
20-day SMA: | 17.04 | Sell |
50-day SMA: | 17.12 | Sell |
200-day SMA: | 20.41 | Sell |
8-day EMA: | 15.17 | Sell |
20-day EMA: | 16.32 | Sell |
50-day EMA: | 17.45 | Sell |
200-day EMA: | 20.92 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.21 | Buy |
20-day SMA: | 123.84 | Buy |
50-day SMA: | 106.16 | Buy |
200-day SMA: | 96.43 | Buy |
8-day EMA: | 127.83 | Buy |
20-day EMA: | 122.76 | Buy |
50-day EMA: | 111.5 | Buy |
200-day EMA: | 99.07 | Buy |
Pros Holdings Earnings Growth & PRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.24 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Pros Holdings Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |